Cour Pharmaceuticals Development Co., Inc.’s Post

More than 70,000 people are diagnosed with #MyastheniaGravis in the U.S. alone, and there is currently no cure. During #MGAwarenessMonth, we stand with MG patients as we work to develop an innovative new treatment option to give patients a better tomorrow. Our candidate CNP-106 is currently in a Phase 2 #ClinicalTrial for the treatment of MG. Learn more about the trial here: https://bit.ly/4c2AgLP #MGStrong

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics